XML 53 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8
Geographic and Product Data
 6 Months Ended
Jul. 04, 2014
Segment Reporting [Abstract]  
Segment Reporting Disclosure [Text Block]
Note 9 — Geographic and Product Data
 
The Company markets and sells its products in over 60 countries and has two manufacturing sites in the United States. During the quarter ended July 4, 2014, the Company completed the consolidation of its Swiss manufacturing facility to the U.S. Other than the United States, Japan, Korea, China, Spain, France and Germany, the Company does not conduct business in any country in which its sales exceed 5% of consolidated sales. Sales are attributed to countries based on location of customers. The composition of the Company’s net sales to unaffiliated customers is set forth below (in thousands):
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
July 4,
 
June 28,
 
July 4,
 
June 28,
 
 
 
2014
 
2013
 
2014
 
2013
 
Japan
 
$
4,549
 
$
4,648
 
$
9,557
 
$
9,387
 
United States
 
 
2,926
 
 
3,154
 
 
5,801
 
 
6,394
 
China
 
 
2,535
 
 
2,230
 
 
4,759
 
 
4,301
 
Korea
 
 
1,952
 
 
1,834
 
 
4,573
 
 
3,869
 
Spain
 
 
1,474
 
 
1,163
 
 
3,092
 
 
2,454
 
France
 
 
1,190
 
 
595
 
 
2,136
 
 
1,127
 
Germany
 
 
1,015
 
 
611
 
 
1,912
 
 
1,126
 
Other
 
 
4,407
 
 
3,929
 
 
8,396
 
 
7,507
 
Total
 
$
20,048
 
$
18,164
 
$
40,226
 
$
36,165
 
 
100% of the Company’s sales are generated from the ophthalmic surgical product segment, and therefore the Company operates as one operating segment for financial reporting purposes. The Company’s principal products are implantable Collamer lenses (“ICLs”) used in refractive surgery and intraocular lenses (“IOLs”) used in cataract surgery. The composition of the Company’s net sales by product line is as follows (in thousands):
 
 
 
Three Months Ended
 
Six Months Ended
 
 
 
July 4,
 
June 28,
 
July 4,
 
June 28,
 
 
 
2014
 
2013
 
2014
 
2013
 
ICLs
 
$
12,172
 
$
11,261
 
$
24,413
 
$
21,892
 
IOLs
 
 
6,428
 
 
5,863
 
 
13,041
 
 
12,211
 
Core products
 
 
18,600
 
 
17,124
 
 
37,454
 
 
34,103
 
Other surgical products
 
 
1,448
 
 
1,040
 
 
2,772
 
 
2,062
 
Total
 
$
20,048
 
$
18,164
 
$
40,226
 
$
36,165
 
 
One customer accounted for 11% of net sales for the three and six months ended July 4, 2014. This customer accounted for 11% and 10% of net sales for the three and six months ended June 28, 2013. One customer accounted for 12% of net sales for the six months ended July 4, 2014. This customer accounted for 10% and 11% of net sales for the three and six months ended June 28, 2013, respectively.
 
The Company sells its products internationally, which subjects the Company to several potential risks including regional/country economic conditions and regulatory requirements, including fluctuating foreign currency exchange rates (to the extent the Company’s transactions are not in U.S. dollars), regulation of fund transfers by foreign governments, United States and foreign export and import duties and tariffs, and political instability.